LncRNA XIST gene knock-in animal model construction method based on RNA targeted binding site

A technology targeting binding sites and RNA targeting, applied in the field of LncRNAXIST gene knock-in animal model construction, can solve the problem of high gene off-target rate, achieve the effect of reducing the off-target rate and improving the success rate

Pending Publication Date: 2022-07-22
AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Aiming at the problem that the traditional CRISPR / Cas9 technology in the prior art has a full length of 17.9kb and contains seven exons, the LncRNA XIST gene knock-in process has a high gene off-target rate caused by too long fragments, the present invention provides a The construction method of LncRNA XIST gene knock-in animal model based on RNA targeting binding site is a CRISPR / Cas9 technology LncRNA XIST gene knock-in animal model construction based on LncRNAXIST and microRNA mmu-miR-140-5p targeting binding site Method, by knocking in the exon of the LncRNA containing the targeting binding site of LncRNA and microRNA, the purpose of studying the effect of LncRNA targeting and binding to microRNA can be achieved, which can reduce the gene knockdown caused by the excessive length of LncRNA and containing multiple exons. The difficulty of entry, realize the research on the direction of lncRNA targeting and binding microRNA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • LncRNA XIST gene knock-in animal model construction method based on RNA targeted binding site
  • LncRNA XIST gene knock-in animal model construction method based on RNA targeted binding site
  • LncRNA XIST gene knock-in animal model construction method based on RNA targeted binding site

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0034] 1. A method for constructing a LncRNA XIST gene knock-in animal model based on RNA targeting binding sites:

[0035] 1) Use the starbase database to perform bioinformatics analysis to confirm the targeted binding site information of LncRNA XIST and microRNA mmu-miR-140-5p, specifically LncRNAs (such as LncRNA XIST) with sequences longer than 10kb and containing multiple exons (such as LncRNA XIST) and microRNAs (such as mmu-miR-140-5p) were confirmed to have targeted binding sites in bioinformatics analysis and in vitro experiments;

[0036] 2) Compare the position of the above-mentioned targeted binding sites in the LncRNA XIST gene through the NCBI database, specifically, LncRNA XIST (length 17.9kb) and mmu-miR-140-5p have been confirmed to have targeting in bioinformatics analysis and in vitro experiments. binding site;

[0037] 3) Compare the above-mentioned targeted binding site in the seventh exon of the LncRNA XIST gene through the NCBI database;

[0038] 4) Th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a construction method of an LncRNA XIST gene knock-in animal model based on an RNA targeted binding site. Comprising the following steps: bioinformatics analysis of a seventh exon of an XIST gene on a targeted binding site of the XIST gene and mmu-miR-140-5p, in-vitro experiments prove that the targeted binding site of the XIST gene and mmu-miR-140-5p in bioinformatics analysis, sgRNA vector construction of the seventh exon containing the targeted binding site of a targeted mouse XIST gene, in-vitro transcription of sgRNA, and acquisition and identification of an F0 generation mouse. The XIST gene is knocked into an animal model in the acquisition process of F1-generation hybrid mice and the acquisition process of homozygous offspring, so that the problem of high off-target rate of the gene caused by overlong fragment in the knock-in process of the CRISPR / Cas9 for the XIST gene with the full length reaching 17.9 kb and containing seven exons is solved.

Description

【Technical field】 [0001] The invention belongs to the technical field of bioengineering, and in particular relates to a method for constructing an LncRNAXIST gene knock-in animal model based on RNA targeting binding sites. 【Background technique】 [0002] The CRISPR / Cas system is a technology derived from the acquired immunity of bacteria for targeted modification of target genes by RNA-mediated Cas proteins. After successfully knocking out mammalian cells in 2013, the Type II CRISPR / Cas9 system modified by researchers has now been applied to gene knockout in various model organisms. The CRISPR / Cas9 system vector construction is simple, fast, easy to operate, saves time and effort, and is applicable to almost all species. The roles of CRISPR / Cas9 and TALEN (Transcription Activator-like Effector Nucleases) are to achieve double-strand breaks at specific sites on the chromosome, and then trigger autonomous damage repair, which will lead to insertion or deletion, resulting in p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G16B5/00G16B20/30G16B50/00G16B15/30C12N15/85A01K67/027
CPCG16B5/00G16B20/30G16B50/00G16B15/30C12N15/85A01K67/0278C12N2800/107A01K2227/105A01K2267/03
Inventor 肖波李良贤莫碧文姚冬马礼兵
Owner AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products